Getting an effective blood biomarker test for TBI from bench to bedside with FDA-approval along the way is no small feat. Dr. Ronald Hayes talks about two proteins for which researchers have high hopes.
See more videos with Dr. Ronald Hayes.
Posted on BrainLine April 2, 2013.
Produced by Brian King, Vicky Youcha, and Erica Queen, BrainLine.
About the author: Ronald Hayes, PhD
Ronald Hayes, PhD is a co-founder and president of Banyan Biomarkers, Inc. He is director of Banyan’s Clinical Programs and Banyan Laboratories.
